- Home
- LUNG vs MCHX Comparison
LUNG vs MCHX Comparison
Compare LUNG & MCHX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LUNG | MCHX |
|---|---|---|
| Founded | 1995 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 63.6M | 71.6M |
| IPO Year | 2020 | 2004 |
Fundamental Metrics
Financial Performance| Metric | LUNG | MCHX |
|---|---|---|
| Price | $2.22 | $1.64 |
| Analyst Decision | Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $6.81 | N/A |
| AVG Volume (30 Days) | ★ 986.2K | 17.3K |
| Earning Date | 11-12-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $91,664,000.00 | $46,494,000.00 |
| Revenue This Year | $9.21 | N/A |
| Revenue Next Year | $5.03 | $6.70 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 15.59 | N/A |
| 52 Week Low | $1.31 | $1.26 |
| 52 Week High | $9.37 | $2.31 |
Technical Indicators
Market Signals| Indicator | LUNG | MCHX |
|---|---|---|
| Relative Strength Index (RSI) | 52.16 | 49.67 |
| Support Level | $2.16 | $1.60 |
| Resistance Level | $2.65 | $1.73 |
| Average True Range (ATR) | 0.19 | 0.07 |
| MACD | -0.03 | 0.01 |
| Stochastic Oscillator | 36.43 | 37.36 |
Price Performance
Historical ComparisonAbout LUNG Pulmonx Corporation
Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). The company's solutions are comprised of the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment System and the StratX Lung Analysis Platform. It generates revenue through the sale of products to distributors and hospitals in the United States which a key revenue generating market, Europe, Middle-East and Africa, Asia Pacific and other regions.
About MCHX Marchex Inc. Class B
Marchex Inc harnesses the power of AI and conversational intelligence to provide actionable insights aligned with prescriptive vertical market data analytics, driving operational excellence and revenue acceleration. Marchex enables executive, sales, and marketing teams to optimize customer journey experiences across communications channels, enabling enterprise strategies, empowering businesses to increase revenue through informed decision-making and strategic execution.